Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant.
Transplant Cell Ther
; 27(9): 776.e1-776.e13, 2021 09.
Article
in En
| MEDLINE
| ID: mdl-34087452
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Graft vs Host Disease
Limits:
Humans
Language:
En
Journal:
Transplant Cell Ther
Year:
2021
Type:
Article
Affiliation country:
Italy